Skip to main content
    I

    Instil Bio Inc. (TIL)

    Official site

    HEALTHCARE • BIOTECHNOLOGY • NASDAQ

    $5.40
    -0.35 (-6.09%)

    Market Cap: $41.23M

    Last updated: Nov 17, 2026 at 4:10 PM ET

    Instil Bio Inc. (TIL) Statistics

    Updated Nov 17, 2026. Figures from company filings and market prices; estimates from consensus analysts.

    Instil Bio (TIL) has a market cap of $41.23M and an enterprise value of $123.75M. Revenue fell 100.00% over the last 12 months from the 12 months before. Its net debt of $82.51M equals 200.11% of its market cap.

    Total Valuation

    Enterprise value is 200.11% above the market cap, as debt exceeds cash.

    Market Cap$41.23M
    Enterprise Value$123.75M
    Latest price (Nov 17, 2026)$5.40

    Key Dates

    The next earnings report is expected on Mar 25, 2027, covering the quarter ending Dec 31, 2026.

    Next Earnings DateMar 25, 2027 (expected)
    Last Earnings DateNov 16, 2026
    Fiscal Year EndDecember

    Share Statistics

    The share count held steady in the quarter ended Sep 30, 2026 and grew 2.09% a year over 2 years.

    Shares Outstanding6.78M
    Shares Change (YoY)+0.36%
    Shares Change (QoQ)0.00%
    Share Count Growth (2Y CAGR)+2.09%

    Price Statistics

    The stock is down 62.55% over 52 weeks and trades 18.80% below its 50-day average.

    Beta (1Y)0.42
    52-Week Change-62.55%
    1-Month Change-6.74%
    3-Month Change-26.93%
    6-Month Change-32.67%
    5-Year Change-98.33%
    Total Return (1Y)-62.55%
    Total Return (3Y CAGR)-9.14%
    Total Return (5Y CAGR)-58.67%
    Return vs SPY (1Y)-70.02%
    Max Drawdown (1Y)-58.90%
    Max Drawdown (3Y)-93.61%
    Sharpe Ratio (1Y)-1.14
    Correlation with SPY (1Y)0.07
    50-Day Average$6.65
    200-Day Average$7.64
    52-Week Range$5.28 to $13.50
    RSI (14 Days)31.0
    Average Volume (20 Days)75.74K

    The 5-year change compares month-end closes, adjusted for splits, through Oct 2026.

    Price chart

    Financial Position

    Current assets cover 10.42x current liabilities, and total debt is 0.83x shareholder equity.

    Current Ratio10.42x
    Quick Ratio10.42x
    Debt / Equity0.83x
    Interest Coverage-4.54x

    Returns and Efficiency

    Return on invested capital is -11.95% over the last 12 months, against a 5-year average of -37.03%.

    Return on Equity (ROE)-20.40%
    Return on Assets (ROA)-10.70%
    Return on Invested Capital (ROIC)-11.95%
    ROE (5Y Average)-53.17%
    ROA (5Y Average)-36.59%
    ROIC (5Y Average)-37.03%

    Scores

    TIL has a Piotroski F-Score of 2 of 9, in the weak band of 0 to 2.

    Piotroski F-Score2 of 9
    Piotroski StrengthWeak

    Income Statement

    Revenue was $0 over the last 12 months.

    Revenue$0
    Revenue Growth (YoY)-100.00%
    Gross Profit-$12.00K
    Operating Income-$28.13M
    Pretax Income-$20.91M
    Net Income-$20.93M
    Reported EPS (TTM)-$2.84

    Trailing 12 months through Sep 30, 2026.

    Full financial statements

    Balance Sheet

    Shareholder equity funds 52.42% of the $195.65M in total assets.

    Cash and Equivalents$2.54M
    Total Debt$85.06M
    Net Debt$82.51M
    Net Debt Per Share$12.17
    Working Capital$59.22M
    Shareholder Equity$102.56M
    Book Value Per Share$15.12
    Total Assets$195.65M
    Total Liabilities$93.08M

    Balance sheet as of Sep 30, 2026.

    Full balance sheet

    Cash Flow

    Operating Cash Flow-$15.46M
    FCF Per Share-$2.28
    Depreciation and Amortization$1.33M

    Trailing 12 months through Sep 30, 2026.

    Full cash flow statement

    Growth

    Book Value Per Share Growth (2Y CAGR)-30.83%
    Tangible Book Per Share Growth (2Y CAGR)-30.83%

    Revenue and profit by year

    Stock Splits

    The last split was a 1-for-20 reverse split on Dec 8, 2023.

    Last Split DateDec 8, 2023
    Split TypeReverse split
    Split Ratio1:20

    Price Target

    Analyst price targets are part of paid GNG plans. See plans

    Frequently Asked Questions About TIL

    What is TIL's market cap?

    Instil Bio has a market cap of $41.23M. Its enterprise value, which adds debt and subtracts cash, is $123.75M.

    How many shares of TIL are outstanding?

    Instil Bio has 6.78M shares outstanding. The count is up 0.36% from a year earlier.

    Does TIL pay a dividend?

    No. Instil Bio does not pay a dividend.

    How much debt does TIL have?

    Instil Bio has $85.06M of total debt and $2.54M of cash and equivalents, a net debt position of $82.51M.